Initiation of Commercialization of ProNephro AKI (NGAL) for Diagnostic Use in the US
This purchase order is to service US hospitals through BioPorto’s distribution relationship with Roche Diagnostics.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330